Hypoglossal Nerve Stimulation: An Innovative Treatment for Sleep Apnea?

Author Note

I’m a long-term CPAP user (10+ years) and sleep apnea patient advocate—not a medical professional. I have NOT personally tried hypoglossal nerve stimulation (HNS), so this article is based entirely on published clinical research, FDA documentation, and expert medical sources—not personal experience.

I’ve successfully managed my severe sleep apnea with CPAP therapy, but I recognize that CPAP doesn’t work for everyone. This article summarizes what I’ve learned through researching HNS as an alternative treatment option. The information here is intended to help you have informed discussions with your sleep medicine provider, not to recommend or discourage this treatment.

All surgical decisions should be made in consultation with board-certified sleep medicine physicians and otolaryngologists who specialize in sleep surgery.

What Is Hypoglossal Nerve Stimulation (HNS)?

Hypoglossal nerve stimulation is an FDA-approved surgical treatment for moderate-to-severe obstructive sleep apnea (OSA) in patients who cannot tolerate or benefit from CPAP therapy.

The procedure involves implanting a small device, similar to a cardiac pacemaker, that stimulates the hypoglossal nerve during sleep. The hypoglossal nerve controls tongue movement, and when stimulated, causes the tongue to move forward slightly, preventing it from collapsing backward and obstructing the airway.[1]

FDA Approval and Clinical Background

In April 2014, the U.S. Food and Drug Administration approved the Inspire Medical Systems Upper Airway Stimulator (commonly called “Inspire therapy”) based on the landmark STAR (Stimulation Therapy for Apnea Reduction) trial published in The New England Journal of Medicine.[2][3] This was a significant milestone—the first implantable device approved specifically for treating obstructive sleep apnea.

According to research published by the National Institutes of Health, as of 2018, over 30,000 patients worldwide have been implanted with HNS devices, with that number growing significantly since then.[1][4] In August 2025, the FDA approved a second HNS device—the Nyxoah Genio system—providing patients with an additional option.[5]

How Hypoglossal Nerve Stimulation Works

According to clinical research and manufacturer documentation, the HNS system consists of three main components:[1][6]

1. Implantable Pulse Generator (IPG)

Implanted under the skin in the upper chest (similar to a pacemaker placement)
Generates electrical pulses that stimulate the hypoglossal nerve
Battery-powered and designed to last several years
Controlled by a small handheld remote

2. Breathing Sensor (Pressure Sensor)

Placed between the ribs in the 4th or 5th intercostal space
Detects intrathoracic pressure changes during breathing
Sends signals to the pulse generator to synchronize stimulation with natural breathing rhythm
Only the Inspire device uses this sensor; other systems use different approaches[1]

3. Stimulation Lead

Surgically attached to the medial branch of the hypoglossal nerve in the neck
Clinical trials found that stimulating the medial branch (vs. the entire nerve trunk) produced better outcomes[1][3]
Delivers mild electrical impulses timed with inhalation

How It Works During Sleep:

When the breathing sensor detects inhalation, it signals the pulse generator to deliver a mild electrical pulse to the hypoglossal nerve. This causes the genioglossus muscle (main tongue muscle) to contract slightly, moving the tongue forward and stiffening the airway. This prevents airway collapse and maintains breathing. During exhalation, stimulation stops and muscles relax.[6]

Patient Control:

Patients use a small remote to turn the device on before sleep and off upon waking. The stimulation strength can be adjusted by the sleep medicine team during follow-up visits to optimize effectiveness and comfort.[1]

Clinical Trial Results: What the Research Shows

The Landmark STAR Trial (2014)

The pivotal FDA approval study, published in The New England Journal of Medicine, provided the foundational evidence for HNS therapy:[2]

Study Design:

126 patients with moderate-to-severe OSA
Patients who could not tolerate CPAP therapy
AHI (Apnea-Hypopnea Index) between 15-65 events per hour
BMI less than 32
Followed for 12 months post-implantation

Results at 12 Months:

68% of patients achieved treatment success (defined as 50% reduction in AHI and AHI < 20)
Median AHI reduced from 29.3 to 9.0 events per hour (69% reduction)
Oxygen Desaturation Index improved by 70%
Epworth Sleepiness Scale scores improved significantly
Functional Outcomes of Sleep Questionnaire scores improved markedly
Quality of life measures showed substantial improvement

Safety:

Device-related serious adverse events occurred in only 2% of patients
No permanent injuries to the hypoglossal nerve reported
Most common side effect: temporary tongue discomfort during initial titration

Long-Term Follow-Up (5-Year Data)

According to research published in Sleep and analyzed by the National Institutes of Health, 71 patients from the original STAR trial consented to 5-year follow-up assessment:[1][7]

75% maintained durable treatment response at 5 years
AHI reductions were sustained
Quality of life improvements persisted
Serious device-related adverse events remained low (6% cumulative over 5 years)
Events were primarily related to lead adjustments, not nerve damage

Real-World Outcomes (Post-FDA Approval)

Multiple studies examining real-world outcomes after FDA approval have shown even better results than the original clinical trial:[4]

Cleveland Clinic Data (2017):

According to Cleveland Clinic surgical sleep specialists, among 27 patients who received HNS in 2017:[8]

Preoperative AHI: Average of 46 events per hour
Postoperative AHI: Average of 4.6 events per hour (90% reduction)
Results were “far superior” to traditional surgical options like UPPP when matched for patient characteristics

Why Real-World Outcomes Are Better:

As noted in ENT Today, real-world outcomes appear better than initial trial results because:[4]

Surgical techniques have been refined since initial trials
Patient selection criteria have been optimized through drug-induced sleep endoscopy (DISE)
Surgeons have gained experience with implantation and programming
Follow-up protocols have improved

Device Safety Data

A comprehensive safety analysis published in the Journal of Clinical Sleep Medicine examined data from 20,881 patients who received HNS implants:[9]

Findings:

1-year explant (removal) rate: 0.723%
1-year revision rate: 1.542%
3-year cumulative explant rate: 3.6%
3-year cumulative revision rate: 7.1%

These rates are comparable to other implantable medical devices and suggest a “satisfactory benefit-to-risk ratio” according to the researchers.[9]

Who Is a Candidate for Hypoglossal Nerve Stimulation?

According to FDA approval criteria and clinical guidelines, HNS is specifically indicated for patients who meet ALL of the following requirements:[1][2][3]

Medical Criteria:

✅ Moderate-to-severe obstructive sleep apnea

AHI between 15-65 events per hour (some newer guidelines extend to AHI 15-100)[10]
Diagnosis confirmed by sleep study

✅ CPAP intolerance or failure

Patient has tried CPAP therapy
Cannot tolerate CPAP despite mask adjustments and desensitization efforts
OR does not achieve adequate AHI reduction with CPAP

✅ Body Mass Index (BMI) < 32 (original criteria)

Some centers now accept BMI up to 35 with updated research[4]
Obesity contributes to sleep apnea in ways HNS may not fully address

✅ Favorable airway anatomy

Assessed through drug-induced sleep endoscopy (DISE)[1][8]
Exclusion: Complete concentric collapse of the soft palate
Requires collapse pattern that involves the tongue base
Must have anterior-posterior (AP) collapse pattern for best results

✅ Age 18 or older (FDA approval for adults)

Clinical trials for adolescents with Down syndrome are underway and showing promising results[4]

✅ No central sleep apnea

HNS is designed specifically for obstructive sleep apnea
Not effective for central sleep apnea where the brain fails to signal breathing muscles

The Drug-Induced Sleep Endoscopy (DISE) Requirement

According to research from Cleveland Clinic and published in peer-reviewed journals, DISE is a critical pre-surgical assessment:[1][8]

What DISE Involves:

Patient is sedated to simulate natural sleep
Otolaryngologist examines upper airway with a flexible scope
Identifies specific patterns and locations of airway collapse

Why It Matters:

Research from the original STAR trial showed that collapse pattern predicts HNS success:[1]

Patients with anterior-posterior (AP) velopharyngeal collapse: ~80% success rate
Patients with complete concentric collapse: <50% success rate (now excluded)

Current Use:

DISE is now standard practice before HNS implantation and is required by Medicare and most insurance companies for coverage approval.[11]

Benefits of Hypoglossal Nerve Stimulation

Based on clinical trial data and patient-reported outcomes published in medical journals:[2][3][4]

1. Significant AHI Reduction

Median 68-75% reduction in apnea-hypopnea events
Many patients achieve AHI < 5 (normal range)
Sustained improvement over 5+ years in most patients

2. Improved Sleep Quality and Daytime Function

Epworth Sleepiness Scale scores improve significantly (reduced daytime sleepiness)
Functional Outcomes of Sleep Questionnaire (FOSQ) scores improve markedly
Patients report feeling more rested and alert during the day
Cognitive function improvements documented

3. No External Equipment Required

Once implanted, no mask, hoses, or bedside machine needed
Can sleep in any position without dislodging equipment
No noise from external devices
Partners report improved sleep quality (no CPAP noise or mask air leaks)

4. High Patient Satisfaction

Over 70% of patients are able to stop using CPAP completely[4]
Quality of life improvements persist long-term
Most patients would recommend the treatment to others

5. Minimally Invasive Procedure

Outpatient surgery (go home same day)
Three small incisions: neck, chest, and ribcage
Typically 2-3 hour procedure
Most patients return to normal activities within 1-2 weeks

6. Adjustable and Reversible

Stimulation settings can be optimized over time
Device can be turned off if issues arise
Can be explanted if absolutely necessary (though rare)

7. Cleveland Clinic Recognition

The Inspire device was awarded “Top 10 Medical Innovation of the Year” by Cleveland Clinic in 2018, recognizing its unique approach to treating sleep apnea by addressing airway tone rather than just anatomy.[4]

Risks and Considerations

As with any surgical procedure, HNS involves risks and limitations. According to published safety data:[1][2][9]

Surgical Risks (Short-Term)

Infection at incision sites (< 2% of cases)
Bleeding or hematoma formation
Pain and swelling during recovery (usually resolves within 2-4 weeks)
Temporary tongue weakness or discomfort
Reactions to anesthesia

Device-Related Risks

Tongue discomfort or unusual sensations during stimulation (most common)
- Usually improves as patients adjust to therapy over 2-3 months
- Stimulation settings can be adjusted for comfort
Device malfunction requiring reprogramming or revision (1.5% at 1 year)[9]
Lead displacement requiring repositioning (rare)
Infection around implant requiring antibiotics or removal (< 1%)

Long-Term Considerations

Battery replacement eventually needed (device lifespan typically 7-11 years)
Regular follow-up required for programming and monitoring
MRI compatibility: Device is MRI-conditional (can have MRIs with certain protocols)
Air travel: Device sets off metal detectors; carry medical ID card

Important Limitations

Not a Cure:

HNS manages OSA symptoms but doesn’t cure the underlying condition. Patients typically still need to:[1]

Maintain healthy weight
Avoid alcohol before bedtime (can worsen airway collapse)
Practice good sleep hygiene
Continue follow-up with sleep medicine team

Not for Everyone:

About 20-30% of patients don’t achieve sufficient AHI reduction
Effectiveness depends on anatomy and collapse pattern
Requires commitment to device use and follow-up

Adjustment Period:

According to otolaryngologists who perform HNS implantation, patients should expect a 2-3 month adjustment period during which stimulation is gradually increased.[4] During this time:

Multiple follow-up visits required for programming
Sensation may feel strange initially
Full benefits may not be realized for several months

The Implantation Procedure

Based on surgical descriptions published by Cleveland Clinic and University of Miami medical centers:[6][8]

Before Surgery:

Comprehensive sleep evaluation with polysomnography
Drug-induced sleep endoscopy (DISE) to assess airway anatomy
Insurance authorization process (typically 2-4 weeks)
Pre-operative clearance and medical optimization

During Surgery:

Procedure Details:

Performed as outpatient surgery under general anesthesia
Typically takes 2-3 hours
Three surgical sites:

1. Neck incision:

Small incision under the jaw to access the hypoglossal nerve
Careful dissection to isolate the medial branch only (controls tongue protrusion)
Stimulation lead wrapped around the nerve

2. Chest incision:

Small incision above the pectoralis muscle
Pulse generator (IPG) placed in a subcutaneous pocket

3. Ribcage incision:

Small incision between ribs (4th or 5th intercostal space)
A breathing sensor is placed between the intercostal muscles
All three components are connected via tunneled wires under the skin
Incisions closed with dissolvable sutures

After Surgery:

Same-day discharge in most cases
Pain managed with oral medications
Device turned on 1-2 weeks after surgery once swelling resolves
Gradual titration over 2-3 months to find optimal settings

Recovery Timeline:

Most patients return to work within 1-2 weeks
Avoid heavy lifting for 2-4 weeks
Full recovery typically 4-6 weeks

Cost and Insurance Coverage

Device and Procedure Cost

According to research published in JAMA Otolaryngology and analysis of manufacturer financial data:[12]

Total Medicare Payment (2018 data):

$28,367 per procedure total
Hospital reimbursement: $27,700
Physician reimbursement: $667

Cost Breakdown:

Device production cost: ~$4,657
Manufacturer markup: ~$18,743 (66% of total payment)
Average device selling price: ~$23,400

For Private Insurance:

Costs vary widely by region and insurance contract
Typical range: $30,000-$50,000 for entire procedure
Out-of-pocket costs depend on deductible, coinsurance, and out-of-pocket maximum

Insurance Coverage

According to the American Academy of Sleep Medicine and Medicare documentation:[11]

Medicare:

Covers HNS under Local Coverage Determinations (LCDs)
All seven Medicare Administrative Contractors have established coverage policies
Specific criteria must be met (documented CPAP failure, DISE results, BMI requirements)
Prior authorization typically required

Private Insurance:

Most major insurers now provide coverage for HNS
Each plan has specific criteria
Pre-authorization almost always required
Coverage typically requires:
- Documentation of CPAP trial and failure/intolerance
- Sleep study confirming moderate-to-severe OSA
- DISE showing favorable anatomy
- BMI within limits
- Medical necessity documentation from sleep specialist

Coverage Considerations:

According to cost-effectiveness research, HNS has an incremental cost-effectiveness ratio (ICER) of approximately $30,000-40,000 per quality-adjusted life year (QALY).[1] This is:

Below the generally accepted U.S. threshold of $40,000-50,000/QALY
More expensive than CPAP ($15,915/QALY)
But potentially cost-effective for CPAP-intolerant patients

Out-of-Pocket Costs:

Even with insurance coverage, patients may face:

Deductibles (potentially $1,000-$6,000)
Coinsurance (typically 10-30% of allowed amount)
DISE procedure costs (separate from implant)
Follow-up visit copays for device programming

Financial Assistance:

Inspire Medical Systems offers a Patient Assistance Program for qualified patients. Contact your implanting surgeon’s office or Inspire directly for information.

Comparing HNS to Other Sleep Apnea Treatments

HNS vs. CPAP

Factor	CPAP	HNS
Effectiveness (AHI reduction)	90-95% reduction	68-75% reduction
Adherence rates	30-60% long-term	85-90% long-term
External equipment	Yes (mask, hose, machine)	No
Surgical procedure	No	Yes
Cost	$500-3,000 initial + ~$500/year supplies	$30,000-50,000 one-time
Adjustment period	2-6 weeks	2-3 months
Reversible	Yes (stop anytime)	Yes (but requires removal surgery)

Key Insight:

While CPAP is more effective at reducing AHI, HNS has much higher long-term adherence because it doesn’t require nightly external equipment. For patients who cannot tolerate CPAP, HNS provides a viable alternative with good outcomes.[1][2]

HNS vs. Traditional Sleep Surgery (UPPP, MMA)

According to Cleveland Clinic research comparing surgical outcomes:[8]

UPPP (Uvulopalatopharyngoplasty):

Success rates: 40-60%
HNS showed superior outcomes in head-to-head comparison
UPPP is permanent and irreversible; HNS is adjustable

MMA (Maxillomandibular Advancement):

Success rates: 75-90% (similar or better than HNS)
More invasive procedure (jaw surgery)
Longer recovery (6-12 weeks vs. 1-2 weeks)
Changes facial appearance
HNS less invasive alternative

HNS Advantage:

HNS is the first treatment to address airway tone (muscle control) rather than just anatomy. This is a fundamentally different approach that works for patients who might not respond to anatomic surgeries.[4]

Latest Developments (2024-2025)

New FDA-Approved Device: Nyxoah Genio

In August 2025, the FDA approved a second HNS system based on results from the DREAM (Dual-sided hypoglossal neRvE stimulAtion) clinical trial:[5]

Key Differences from Inspire:

Bilateral stimulation (both sides of tongue) vs. unilateral
No breathing sensor required (different stimulation pattern)
Potentially simpler surgical implantation
Battery is rechargeable (worn as chip under chin during sleep)

DREAM Trial Results:

115 patients enrolled
Similar safety profile to Inspire
Efficacy data showing meaningful AHI reduction
Provides patients with a second option for HNS therapy

Expanding Indications

Adolescents with Down Syndrome:

Clinical trials investigating HNS for adolescents and young adults with Down syndrome have shown very promising results:[4]

At least 50% reduction in AHI across all studies
Improvements in daytime function, behavior, and even speech
Multi-center trial currently underway
May receive FDA approval for this indication soon

Relaxed BMI Requirements:

Some surgeons and insurance companies now accept patients with BMI up to 35 (vs. original limit of 32) based on emerging real-world outcome data.[4]

Questions to Ask Your Sleep Medicine Provider

If you’re considering HNS, the American Academy of Sleep Medicine and sleep surgery experts recommend discussing:[1][11]

About Your Candidacy:

Based on my sleep study, am I a candidate for HNS?
What is my current AHI, and what AHI reduction can I realistically expect?
Do I need drug-induced sleep endoscopy (DISE) to determine my eligibility?
What does my airway collapse pattern look like?
Is my BMI within acceptable limits?

About The Procedure:

How many HNS implants have you personally performed?
What are your patient outcomes (average AHI reduction)?
What is your complication rate?
What type of anesthesia is used?
What does the recovery period look like?

About Results and Follow-Up:

How long before I see full benefits?
How often will I need follow-up appointments for programming?
What happens if the device doesn’t work well for me?
What are realistic expectations for AHI reduction in someone with my characteristics?

About Costs:

What is the total cost of the procedure?
Does my insurance cover HNS, and what will my out-of-pocket costs be?
What costs are involved with DISE and other pre-surgical evaluations?
Are there financing options available?

About Alternatives:

Are there other surgical options I should consider?
Have we exhausted all CPAP alternatives (different masks, BiPAP, ASV)?
What happens if I do nothing (what are the risks of untreated OSA)?

Is Hypoglossal Nerve Stimulation Right for You?

The Bottom Line:

Hypoglossal nerve stimulation represents a significant advancement in treating obstructive sleep apnea, backed by:

FDA approval based on rigorous clinical trials
Published research in top medical journals (New England Journal of Medicine, JAMA, Sleep)
Over 30,000 patients treated worldwide
5-year data showing durable benefits
Real-world outcomes that meet or exceed clinical trial results

For Whom HNS Makes Sense:

Based on the research, HNS is most appropriate for patients who:[1][2][3]

Have moderate-to-severe OSA (AHI 15-65+)
Genuinely cannot tolerate CPAP despite good-faith efforts
Meet BMI requirements (< 32-35)
Have favorable anatomy on DISE (no complete concentric collapse)
Are willing to commit to the surgical procedure and follow-up care
Understand it’s not a cure and has an adjustment period

Important Considerations:

CPAP should be first-line treatment – It’s more effective and non-invasive
HNS is a surgery that carries inherent risks even though minimally invasive
Success not guaranteed – 20-30% of patients don’t achieve sufficient improvement
Requires commitment – Need to use device nightly and attend follow-up appointments
Cost significant – Even with insurance, out-of-pocket costs can be substantial

My Personal Perspective:

As a CPAP user who has successfully managed severe sleep apnea for 10+ years, I recognize that CPAP works extremely well—when you can tolerate it. But I also know from community discussions and research that many people genuinely cannot tolerate CPAP despite trying multiple masks and extensive desensitization efforts.

For those patients, HNS offers real hope backed by solid clinical evidence. The research is compelling, the FDA approval process was rigorous, and real-world outcomes are encouraging.

However, this is a significant surgical decision that requires careful consideration and expert medical guidance.

Final Thoughts

I created this article because many people ask me about alternatives to CPAP, and hypoglossal nerve stimulation comes up frequently. While I haven’t personally tried HNS (CPAP works well for me), I wanted to provide a comprehensive, research-based overview to help others understand this option.

The research is clear: HNS is an effective, FDA-approved treatment for appropriately selected patients. But it’s not right for everyone, and the decision to pursue it should be made carefully with your sleep medicine team.

If you’re struggling with CPAP, I encourage you to:

First exhaust all CPAP alternatives (different masks, BiPAP, oral appliances)
Then discuss HNS with a board-certified sleep medicine physician
Get evaluated by an otolaryngologist who specializes in sleep surgery and has extensive HNS experience
Understand all costs, risks, and realistic expectations
Make an informed decision based on your specific situation

Have you had HNS or are you considering it? I’d love to hear about your experience or answer questions based on the research I’ve compiled. Leave a comment below—your insights could help others navigating this decision.

References

[1] Huntley C, Steffen A, Doghramji K, et al. Hypoglossal Nerve Stimulation Therapy for the Treatment of Obstructive Sleep Apnea. Neurotherapeutics. 2021;18(1):91-99. https://link.springer.com/article/10.1007/s13311-021-01012-x

[2] Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):139-149. https://www.nejm.org/doi/full/10.1056/NEJMoa1308659

[3] Kezirian EJ, Goding GS Jr, Malhotra A, et al. Insights since FDA Approval of Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea. PMC. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5739331/

[4] ENT Today. New Developments Regarding Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea. February 14, 2023. https://www.enttoday.org/article/new-developments-regarding-hypoglossal-nerve-stimulation-for-obstructive-sleep-apnea/

[5] Kezirian EJ. Nyxoah Genio: DREAM Study Results and FDA Approval! Sleep Doctor. September 1, 2025. https://sleep-doctor.com/blog/nyxoah-genio-dream-study-results-and-fda-approval/

[6] University of Miami Health System. Hypoglossal Nerve Stimulation. https://umiamihealth.org/en/treatments-and-services/ear,-nose,-and-throat-(ent)/hypoglossal-nerve-stimulation

[7] Woodson BT, Soose RJ, Gillespie MB, et al. Three-Year Outcomes of Cranial Nerve Stimulation for Obstructive Sleep Apnea: The STAR Trial. Otolaryngol Head Neck Surg. 2016;154(1):181-188.

[8] Cleveland Clinic. A Closer Look at Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea. August 6, 2025. https://consultqd.clevelandclinic.org/a-closer-look-at-hypoglossal-nerve-stimulation-for-obstructive-sleep-apnea

[9] Thaler E, Schwab R, Maurer J, et al. Device-related outcomes following hypoglossal nerve stimulator implantation. Journal of Clinical Sleep Medicine. 2022. https://jcsm.aasm.org/doi/10.5664/jcsm.11176

[10] Proliance Surgeons. Inspire Sleep Apnea Innovation. March 11, 2024. https://proliancesurgeons.com/inspire-sleep-apnea-innovation/

[11] American Academy of Sleep Medicine. Medicare finalizes LCD policies for hypoglossal nerve stimulation for sleep apnea. July 6, 2020. https://aasm.org/medicare-finalizes-lcd-policies-for-hypoglossal-nerve-stimulation-for-sleep-apnea/

[12] Pietzsch JB, Garner AM, Cipriano LE, Linehan JH. Use and Cost of a Hypoglossal Nerve Stimulator Device for Obstructive Sleep Apnea Between 2015 and 2018. JAMA Otolaryngol Head Neck Surg. 2019;145(11):1064-1065. https://pmc.ncbi.nlm.nih.gov/articles/PMC6707009/

⚠️ MEDICAL DISCLAIMER This blog provides general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Sleep apnea is a serious condition, and CPAP equipment should be used under proper medical supervision. Always consult your doctor or sleep specialist before starting, stopping, or changing any therapy. I share personal experiences as a CPAP user, not as a medical professional. Individual results vary. For medical guidance, please consult a qualified clinician or the American Academy of Sleep Medicine (aasm.org).